-+ 0.00%
-+ 0.00%
-+ 0.00%

*Outlook Therapeutics Plans to Use Proceeds to Help Support Commercial Launch of LYTENAVA(TM) in the U.S. >OTLK

Dow Jones·08/13/2026 02:10:00

Please log in to view news